CURLF News
TSNDF Stock Rises 6.5% in a Month: Time to Buy, Hold or Sell?
TerrAscend's improving revenues, margins and cash flow support its recovery, while debt, competition and regulatory uncertainty remain key concerns.
Zacks
TSNDF Stock Rises 6.5% in a Month: Time to Buy, Hold or Sell?
TerrAscend's improving revenues, margins and cash flow support its recovery, while debt, competition and regulatory uncertainty remain key concerns.
Zacks
TLRY Stock Loses 17% in Three Months: Should You Buy, Hold or Sell?
Tilray's revenues and EBITDA are growing, but weak margins, negative cash flow and competition raise questions about its next move.
Zacks
Are Medical Stocks Lagging Cronos Group (CRON) This Year?
Here is how Cronos Group (CRON) and Curaleaf Holdings, Inc. (CURLF) have performed compared to their sector so far this year.
Zacks
Cannabis Stock CRLBF Surges 10% in a Month: Time to Buy or Sell?
Cresco's 10% monthly rally reflects stronger revenues, organic growth and margins, but competition and normalization risks cloud the outlook.
Zacks
Wall Street Analysts Predict a 43.69% Upside in Curaleaf Holdings, Inc. (CURLF): Here's What You Should Know
The mean of analysts' price targets for Curaleaf Holdings, Inc. (CURLF) points to a 43.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks
Cannabis Stock VRNO Rises 10% in a Month: Time to Buy, Hold or Sell?
Verano's rally follows strong Q2 results, but margin pressure and wider 2026 losses keep the stock in wait-and-watch mode.
Zacks
Aurora Cannabis Highlights Inaccuracies In Curaleaf’s Takeover Bid Announcement— CEO Claims Business Is Reaching Pivotal Inflection Point
Aurora said its Board, along with a newly formed Special Committee of independent directors, is reviewing Curaleaf's proposal as it determines the future course of action.
Cannabis Operator CGC Rises 15% in a Month: Time to Buy, Hold or Sell?
Canopy Growth's cannabis business is showing signs of a turnaround, with revenue growth, improving margins and a narrower EBITDA loss fueling its rally.
Zacks
How Much Upside is Left in Curaleaf Holdings, Inc. (CURLF)? Wall Street Analysts Think 40.63%
The mean of analysts' price targets for Curaleaf Holdings, Inc. (CURLF) points to a 40.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks